{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05980455",
            "orgStudyIdInfo": {
                "id": "CLN 001-PR-00755"
            },
            "organization": {
                "fullName": "Enterra Medical, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of Enterra Programming With Nocturnal Cycling in Gastroparetics",
            "officialTitle": "Randomized Study of Enterra Programming With Nocturnal Cycling in Gastroparetics",
            "acronym": "RESTING",
            "therapeuticArea": [
                "Endocrinology",
                "Other"
            ],
            "study": "study-of-enterra-programming-with-nocturnal-cycling-in-gastroparetics"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-07-31",
            "studyFirstSubmitQcDate": "2023-07-31",
            "studyFirstPostDateStruct": {
                "date": "2023-08-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Enterra Medical, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research study is to evaluate if different Enterra\u00ae device programming methods active during sleeping hours can maintain gastroparesis-related symptom relief and quality of life measures.\n\nParticipants in this study with existing Enterra\u00ae devices will be randomly assigned to one of three programming methods that will be active during sleep. Participants will answer daily questions about their gastroparesis symptoms on an application with their phone/tablet. Participants will answer quality of life questionnaires about their gastroparesis symptoms at study visits.\n\nParticipants will be involved in the study for up to six months after treatment assignment.\n\nProgramming parameters in the study are within currently approved labeling."
        },
        "conditionsModule": {
            "conditions": [
                "Gastroparesis",
                "Gastroparesis Nondiabetic",
                "Gastroparesis Due to Diabetes Mellitus"
            ],
            "keywords": [
                "Gastric electrical stimulation",
                "Gastroparesis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Control Sleep Cycle",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Baseline device programming parameters will be used during study participation. No modification to Enterra\u00ae device programming will be in effect during waking or sleeping hours.",
                    "interventionNames": [
                        "Device: Enterra\u00ae Therapy System"
                    ]
                },
                {
                    "label": "Arm 1 Sleep Cycle",
                    "type": "EXPERIMENTAL",
                    "description": "Device programming parameters participants have at enrollment will be used during waking hours.\n\nDuring sleeping hours, the Enterra\u00ae device will cycle through modified programming over the course of 6 hours. Each hour, the Enterra\u00ae device will deliver 30 minutes of reduced stimulation, followed by 30 minutes of waking hours stimulation. At the end of the 6-hour sleep cycle, the Enterra\u00ae device will return to waking hours programming.",
                    "interventionNames": [
                        "Device: Enterra\u00ae Therapy System"
                    ]
                },
                {
                    "label": "Arm 2 Sleep Cycle",
                    "type": "EXPERIMENTAL",
                    "description": "Device programming parameters participants have at enrollment will be used during waking hours.\n\nDuring sleeping hours, the Enterra\u00ae device will cycle through modified programming over the course of 8 hours. Each hour, the Enterra\u00ae device will deliver 45 minutes of reduced stimulation, followed by 15 minutes of waking hours stimulation. At the end of the 8-hour sleep cycle, the Enterra\u00ae device will return to waking hours programming.",
                    "interventionNames": [
                        "Device: Enterra\u00ae Therapy System"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Enterra\u00ae Therapy System",
                    "description": "The Enterra\u00ae Therapy System for gastric electrical stimulation (GES) is indicated for the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years.",
                    "armGroupLabels": [
                        "Arm 1 Sleep Cycle",
                        "Arm 2 Sleep Cycle",
                        "Control Sleep Cycle"
                    ],
                    "otherNames": [
                        "Gastric electrical stimulation"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percent Change in Weekly Vomiting Frequency by GCSI-DD",
                    "description": "Less than a 50% increase in GCSI-DD weekly vomiting frequency from baseline",
                    "timeFrame": "3 Months, 6 Months"
                },
                {
                    "measure": "Scoring Change in Nausea Severity by GCSI-DD",
                    "description": "Less than a 1-point increase in GCSI-DD nausea severity from baseline",
                    "timeFrame": "3 Months, 6 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean Change from Baseline in GCSI-DD Total Symptom Score",
                    "description": "Change in GCSI-DD Total Symptom Score from baseline",
                    "timeFrame": "3 Months, 6 Months"
                },
                {
                    "measure": "Mean Change from Baseline in GCSI-DD Nausea Severity",
                    "description": "Change in GCSI-DD nausea severity from baseline",
                    "timeFrame": "3 Months, 6 Months"
                },
                {
                    "measure": "Mean Change from Baseline in GCSI-DD Weekly Vomiting Frequency",
                    "description": "Change in GCSI-DD weekly vomiting frequency from baseline",
                    "timeFrame": "3 Months, 6 Months"
                },
                {
                    "measure": "Mean Change from Baseline in PAGI-QoL Scores",
                    "description": "Change in PAGI-QoL from baseline",
                    "timeFrame": "3 Months, 6 Months"
                },
                {
                    "measure": "Mean Change from Baseline in Quality of Sleep Scores",
                    "description": "Change in Quality of Sleep from baseline",
                    "timeFrame": "3 Months, 6 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "In order to be eligible to participate in this study, a participant must meet all of the following criteria:\n\n1. Completed informed consent process with signed and dated informed consent form;\n2. Stated willingness to comply with all study procedures and availability for the duration of the study;\n3. Male or female, aged \u226518 or \u226470 at time of informed consent;\n4. Currently implanted with the Enterra\u00ae Therapy System (Enterra\u00ae II 37800 neurostimulator);\n5. High GES output defined as remaining pulse generator expected life of \\> 9 months from enrollment and less than 4 years from the time of implant;\n6. Stable gastroparesis symptoms, in the opinion of the investigator;\n7. On stable medical therapy for gastroparesis symptoms;\n8. On stable supplemental nutritional support during the month prior to enrollment;\n9. English language comprehension to complete study-required assessments;\n10. Reliable access to internet-connected smart device(s) to complete study-required assessments.\n\nA participant who meets any of the following criteria will be excluded from participation in this study:\n\n1. Post-surgical gastroparesis (e.g., fundoplication, Bilroth I or II) or other active stomach or gastrointestinal diseases disorders which could explain symptoms in the opinion of the investigator;\n2. Subjects, in the opinion of the investigator, with profound nausea and/or vomiting at night;\n3. Subjects, in the opinion of the investigator, with profound gastroparesis symptoms upon waking in the morning;\n4. Subjects without a regular and defined sleep schedule;\n5. Pregnancy, or subject that intends to become pregnant during participation in the study;\n6. Chemical dependency;\n7. Enterra lead impedance measurements \u2265 700 Ohms at screening visit;\n8. Life expectancy \\< 1 year from conditions other than GI diseases;\n9. Subjects with an underlying disease leading to follow-up by MRI outside of current MR conditional indications;\n10. Participation in other clinical studies;\n11. Subjects involved in current or past medical-related litigation;\n12. Subjects with cognitive impairment or other characteristic that would limit subject's ability to complete study requirements.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Timothy McAllister",
                    "role": "CONTACT",
                    "phone": "855-768-3772",
                    "email": "clinicalresearch@enterramedical.com"
                },
                {
                    "name": "Jason Hamann, PhD",
                    "role": "CONTACT",
                    "phone": "855-768-3772",
                    "email": "clinicalresearch@enterramedical.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Abigail Stocker, MD",
                    "affiliation": "University of Louisville",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Louisville",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Abigail Stocker, MD",
                            "role": "CONTACT",
                            "phone": "502-588-4600",
                            "email": "abigail.stocker@louisville.edu"
                        },
                        {
                            "name": "Abigail Stocker, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "MNGI Digestive Health, P.A.",
                    "status": "RECRUITING",
                    "city": "Coon Rapids",
                    "state": "Minnesota",
                    "zip": "55433",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Roxanne Strehlo",
                            "role": "CONTACT"
                        },
                        {
                            "name": "April Grudell, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.11997,
                        "lon": -93.28773
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000018589",
                    "term": "Gastroparesis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000013272",
                    "term": "Stomach Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000010243",
                    "term": "Paralysis"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M20685",
                    "name": "Gastroparesis",
                    "asFound": "Gastroparesis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16062",
                    "name": "Stomach Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13157",
                    "name": "Paralysis",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "T2445",
                    "name": "Gastroparesis",
                    "asFound": "Gastroparesis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}